soul semaglutide trial oral cardiovascular outcomes soul trial results Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes SOUL: Oral Semaglutide Bests Usual

A gradual pace helps your hunger cues, digestion, and energy stay steadier

Patients should work closely with their GP or endocrinologist to achieve stable thyroid function before considering additional weight management interventions

Nausea affects 30% to 44% of people, diarrhea occurs in about 30%, constipation affects 24% to 28%, and vomiting happens in 9% to 15%

Semaglutide (The same active ingredient in Wegovy and Ozempic) is a medication primarily known for its use in managing type 2 diabetes, and helping patients manage weight loss

If weight loss is a priority Semaglutide is FDA-approved for managing weight in patients with obesity and overweight